| Schedule Of Common Stock Activity |
The following table provides common stock activity for the last three years. | | | | | | | | | | | | | | | | | | | COMMON STOCK ACTIVITY | | | | | 2023 | | 2022 | | 2021 | | Sempra: | | | | | | | Common shares outstanding, January 1 | 628,669,356 | | | 633,839,564 | | | 576,940,488 | | | Conversion of mandatory convertible preferred stock | — | | | — | | | 36,075,490 | | | Shares issued under forward sale agreements | 2,099,152 | | | — | | | — | | | Shares issued in IEnova exchange offer | — | | | — | | | 24,613,554 | | RSUs vesting(1) | 941,910 | | | 914,444 | | | 1,373,832 | | | Stock options exercised | — | | | 81,260 | | | 101,342 | | Common stock investment plan(2) | 1,730 | | | — | | | — | | | Issuance of RSUs held in our Deferred Compensation Plan | 132,178 | | | 130,026 | | | 204,476 | | Shares repurchased(3) | (412,594) | | | (6,295,938) | | | (5,469,618) | | | Common shares outstanding, December 31 | 631,431,732 | | | 628,669,356 | | | 633,839,564 | |
(1) Includes dividend equivalents. (2) Participants in the Direct Stock Purchase Plan may reinvest dividends to purchase newly issued shares. (3) Includes shares repurchased under repurchase programs and shares withheld from LTIP participants to satisfy minimum statutory tax withholding requirements.
|
| Schedule Of Noncontrolling Interests |
The following table summarizes net income attributable to Sempra and transfers (to) from NCI, which shows the effects of changes in Sempra’s ownership interest in its subsidiaries on Sempra’s shareholders’ equity. | | | | | | | | | | | | | | | | | | | NET INCOME ATTRIBUTABLE TO SEMPRA AND TRANSFERS (TO) FROM NCI | | (Dollars in millions) | | | Years ended December 31, | | | 2023 | | 2022 | | 2021 | | Sempra: | | | | | | | Net income attributable to Sempra | $ | 3,075 | | | $ | 2,139 | | | $ | 1,318 | | | Transfers (to) from NCI: | | | | | | | Increase in shareholders’ equity for purchases of NCI | — | | | — | | | 1,415 | | | (Decrease) increase in shareholders’ equity for sales of NCI | (49) | | | 710 | | | 1,429 | | | Net transfers (to) from NCI | (49) | | | 710 | | | 2,844 | | | Change from net income attributable to Sempra and transfers (to) from NCI | $ | 3,026 | | | $ | 2,849 | | | $ | 4,162 | |
|
| Schedule Of Earnings Per Share Computations |
| | | | | | | | | | | | | | | | | | | EARNINGS PER COMMON SHARE COMPUTATIONS | | | | | | | (Dollars in millions, except per share amounts; shares in thousands) | | | | | | | | Years ended December 31, | | | 2023 | | 2022 | | 2021 | | Sempra: | | | | | | | Numerator: | | | | | | | Earnings attributable to common shares | $ | 3,030 | | | $ | 2,094 | | | $ | 1,254 | | | | | | | | | Denominator: | | | | | | Weighted-average common shares outstanding for basic EPS(1) | 630,296 | | | 630,318 | | | 623,510 | | Dilutive effect of stock options and RSUs(2) | 2,341 | | | 2,439 | | | 1,506 | | | Dilutive effect of common shares sold forward | 96 | | | — | | | — | | | Dilutive effect of mandatory convertible preferred stock | — | | | — | | | 1,057 | | | Weighted-average common shares outstanding for diluted EPS | 632,733 | | | 632,757 | | | 626,073 | | | | | | | | | EPS: | | | | | | | Basic | $ | 4.81 | | | $ | 3.32 | | | $ | 2.01 | | | Diluted | $ | 4.79 | | | $ | 3.31 | | | $ | 2.01 | |
(1) Includes fully vested RSUs held in our Deferred Compensation Plan of 717 in 2023, 805 in 2022 and 907 in 2021. These fully vested RSUs are included in weighted-average common shares outstanding for basic EPS because there are no conditions under which the corresponding shares will not be issued. (2) Due to market fluctuations of both Sempra common stock and the comparative indices used to determine the vesting percentage of our total shareholder return performance-based RSUs, which we discuss in Note 10, dilutive RSUs may vary widely from period-to-period.
|